Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Refine results:

Refine results


Inside the Lab Digital and computational pathology

Experience & results from using INIFY Prostate Screening –in the fully digitalized pathology workflow at Cannizzaro hospital Italy

, 15:00 GMT | Sponsored by ContextVision

Dr Filippo Fraggetta shares his experience and clinical results of using INIFY Prostate Screening in the fully digitalized workflow at Cannizzaro hospital, Catania, Italy.

Diagnostics Genetics and epigenetics

Opportunities and challenges with comprehensive genomic profiling: the right solution for the right question

, 4pm GMT | Sponsored by Thermo Fisher Scientific

In this webinar, our speakers will discuss the benefits of CGP and how this technique is utilized in their lab.

Subspecialties Microbiology and immunology

COVID-19 Multiorgan Study: Spatial Phenotyping of Immune Cell Subsets in Patients with Lethal COVID-19

| Sponsored by Akoya Biosciences

In this webinar, the speakers will describe how they used multiplexed imaging and single-cell analysis to study the immune response to the SARS-CoV-2 virus across multiple organ systems.

Inside the Lab Digital and computational pathology

Comprehensive Opal Multiplex Validation: From Staining to Digital Image Analysis

| Sponsored by Akoya Biosciences

Optimisation and validation of a multiplex immunofluorescence workflow, from staining to digital image analysis, ensures assay robustness and prepares this technology for deployment in clinical trial analysis and in routine diagnostics.

Subspecialties Oncology

Exploring MSI Screening Technologies

| Sponsored by Promega

Microsatellite Instability (MSI)-High has been identified as a biomarker for immune checkpoint inhibitor therapy in cancers originating in different tissues.

Inside the Lab Precision medicine

Decision support software in the NGS oncology workflow

| Sponsored by Roche

An increasing number of clinical laboratories are using next generation sequencing (NGS) for the molecular characterization of cancer.

Inside the Lab Digital and computational pathology

Redefining Cancer Treatment: Targeting Gene Fusions

| Sponsored by Invitae

ArcherDX , now Invitae is a leading genomics company democratizing precision oncology.

Inside the Lab Digital and computational pathology

AI-based Digital Diagnostics for the Detection of Prostate Cancer

| Sponsored by Paige

Prostate cancer, the most frequently diagnosed cancer in 105 countries and the leading cause of death in 46 countries worldwide, is diagnosed by core needle biopsy.

Diagnostics Biochemistry and molecular biology

Standardizing minimal residual disease (MRD) assessment in lymphoid malignancies using NGS

| Sponsored by Adaptive Biotechnologies

clonoSEQ® Assay is a highly sensitive, specific, and standardized method for detecting and monitoring minimal residual disease (MRD).

Subspecialties Oncology

Validating a targeted NGS approach for molecular characterization of gliomas

| Sponsored by Qiagen

Targeted NGS has been instrumental in driving our understanding of disease.

Outside the Lab Pathologists’ assistants

Pathologists’ Assistants: Bridging the Gap

The Pathologist is delighted to introduce the Pathologists’ Assistants: Bridging the Gap Live Roundtable.

Diagnostics Biochemistry and molecular biology

A new day for myeloid genomic profiling: how NGS advancements are providing deeper insight with faster time to results

| Sponsored by Thermo Fisher Scientific

The use of genomic profiling for myeloid samples has accelerated in recent years due in part to increasing annotation of disease-associated biomarkers.

Inside the Lab Digital and computational pathology

Digital Pathology for Routine Diagnostics: Experiences from Region Skåne & Hospital for Special Surgery

| Sponsored by Sectra

Region Skåne (Sweden) has implemented digital pathology in 4 labs across their enterprise.

Diagnostics Liquid biopsy

Comprehensive genomic profiling from liquid biopsy samples in clinical trials

| Sponsored by Illumina

Clinical trials are increasingly using liquid biopsy samples to complement or as an alternative to invasive tissue sample collections.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine